A nurse is completing an admission assessment for a client who has been taking St. John's wort. The nurse should identify that which of the following medications can interact with St. John's wort?

Choice A rationale Rifampin is a potent inducer of the cytochrome P450 (CYP) enzyme system, specifically CYP3A4, which is responsible for the metabolism of many drugs. St. John's wort is also a strong inducer of this same enzyme. While both medications can affect drug metabolism, the interaction is not a primary concern because they both induce the same pathway rather than competing or causing a synergistic effect that would lead to toxicity. Choice B rationale Furosemide is a loop diuretic that inhibits the reabsorption of sodium and chloride in the loop of Henle. St. John's wort does not have a significant or clinically relevant interaction with furosemide's mechanism of action or its metabolic pathway. The two medications can typically be taken concurrently without requiring special monitoring or dosage adjustments. Choice C rationale Citalopram is a selective serotonin reuptake inhibitor (SSRI), which increases serotonin levels in the synaptic cleft. St. John's wort also possesses serotonergic activity. Taking both together can lead to a dangerous condition known as serotonin syndrome, characterized by a potentially lethal triad of autonomic dysfunction, neuromuscular abnormalities, and mental status changes. Choice D rationale Allopurinol is a xanthine oxidase inhibitor used to treat gout. It reduces the production of uric acid. There is no significant pharmacological interaction or shared metabolic pathway between allopurinol and St. John's wort. The mechanisms of action are distinct, and the combination does not pose a known risk for adverse effects or therapeutic failure.